RxDoctor Payments DataLook up a doctor →

Judd Hunter, NP

Family · Provo, UTNPI 1831428705

Payments from drug & device makers

$31,570in general payments, 2019–2025

Across 641 payments — averaging $49.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$19K
  • Inspire Medical Systems, Inc.$5K
  • Jazz Pharmaceuticals Inc.$2K
  • Harmony Biosciences LLC$933
  • AbbVie$599
  • Avadel CNS Pharmaceuticals, LLC$512
  • plus $4K from 44 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axsome Therapeutics, Inc.119$18,996
Inspire Medical Systems, Inc.127$4,752
Jazz Pharmaceuticals Inc.67$1,831
Harmony Biosciences LLC45$933
AbbVie31$599
Avadel CNS Pharmaceuticals, LLC37$512
Novo Nordisk20$345
AstraZeneca21$312
Lilly USA, LLC16$276
Amgen15$259
Astellas Pharma US Inc11$215
Boehringer Ingelheim12$211
Dexcom, Inc.9$169
GSK9$157
Philips North America LLC5$136
Abbott3$129
Idorsia Pharmaceuticals US Inc2$119
Novartis7$119
Alnylam Pharmaceuticals Inc.1$102
Resmed Corp5$98
Pfizer6$91
Merck5$89
E.r. Squibb & Sons, L.L.C.6$84
Actelion Pharmaceuticals US, Inc.4$83
Fisher & Paykel Healthcare Inc5$80
Daiichi Sankyo Inc.4$77
Exeltis, USA Inc.1$67
Sumitomo Pharma America, Inc.5$55
Sanofi-aventis U.S. LLC3$55
Bayer3$54
Antares Pharma, Inc.4$53
Avanir Pharmaceuticals, Inc.4$52
Sunovion Pharmaceuticals Inc.4$50
Phathom Pharmaceuticals, Inc.3$42
Sanofi Pasteur Inc.2$39
Johnson & Johnson2$39
Neurocrine Biosciences, Inc.2$38
3b Medical, Inc.2$32
Averitas Pharma Inc.1$30
Arbor Pharmaceuticals, Inc.2$25
Eisai Inc.2$23
ARS Pharmaceuticals Operations, Inc.1$20
Biogen1$19
Lundbeck LLC1$17
Azurity Pharmaceuticals, Inc.1$17
Baxter Healthcare1$15
Radius Health, Inc.1$14
Amarin Pharma, Inc.1$14
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$14
Biohaven Pharmaceutical Holding Company Ltd.1$12

How this compares

$31,570 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.

See all family providers in Utah →

Medicare billing

Part B allowed, 2024
$75,693
Medicare patients
467
Services billed
1,383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Provo

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →